Digital Transformation for a Healthy Future, MeditriX
CEO's Message
Striving for innovation and improvement,
we promise to deliver the best value based on our expertise and passion.
Education
- 1991 - 1997 B.A. in Medicine, Seoul National University
- 2001 - 2005 Master of Medicine in Psychiatry from Seoul National University Graduate School of Medicine
- 2005 – 2007 Doctor of Medicine in Psychiatry from Seoul National University Graduate School of Medicine
Work Experience
- 1998 - 2002 Resident at Department of Neuropsychiatry, Seoul National University Hospital
- 2005 - 2007 Clinical Lecturer at Seoul National University Hospital
- 2007 - 2008 Adjunct Professor, Biomedical Research Institute, Seoul National University Hospital
- 2008 - present Professor at Samsung Medical Center with Sungkyunkwan University School of Medicine
- 2012 – 2014 Received training as part of the Depression & Clinical Research Program (DCRP) of Massachusetts General Hospital (MGH) with Harvard Medical School, USA
- 2014 – 2016 Advisory Professor, the Depression & Clinical Research Program (DCRP) of Massachusetts General Hospital (MGH) with Harvard Medical School
- 2017 - 2021 Director of the Korea Psychological Autopsy Center operating as entrusted by the Ministry of Health and Welfare (concurrently)
- 2014 - present Adjunct Professor, Samsung Advanced Institute for Health Sciences & Technology, SKKU (SAIHST)
- 2021 - 2023 Director, Korea Foundation for Suicide Prevention (KFSP, concurrently)
- 2021 - present President of Digital Therapy Research Center at Samsung Medical Center
- 2022 - present Vice Dean of Research, Sungkyunkwan University School of Medicine
- 2022 – present Editor-in-Chief of Precision & Future Medicine at Sungkyunkwan University School of Medicine
- 2022. 6. 3. – present Founder and CEO of Meditrix Co., Ltd.
Greetings! I am Hong-jin Jeon, CEO of MeditriX.
We sincerely thank you all for visiting MeditriX.
Since its establishment on June 3, 2022, MeditriX has been seeking growth with the vision of “providing leading solutions to help everyone live healthier and richer lives through healthcare innovation.”
We are doing our very best to improve the quality of life and create a better future for our customers through rapidly developing technologies such as virtual reality (VR), artificial intelligence (AI), digital therapy, and biometric signal analysis technologies .
We are committed to the pursuit of innovation and improvement in order to live up to the trust and expectations of our customers, and delivering the best value based on our expertise and passion.
Moving forward, MeditriX will constantly take on challenges to forge ahead as a global healthcare leader and will strive to create value for customers and community.
We would like to ask for your continued interest and support, as a sempiternal partner that seeks to grow with our customers.
Thank you.
Hong-jin Jeon, CEO of MeditriX